Salivary alpha amylase activity in migraine patients
- PMID: 20144881
- DOI: 10.1016/j.autneu.2010.01.011
Salivary alpha amylase activity in migraine patients
Abstract
Objective: Salivary alpha amylase levels were measured to investigate sympathetic nervous system activity in migraine patients during attack, post-attack and interval periods of headache since salivary alpha amylase levels have been suggested as a potential indirect marker of sympatho-adrenal medullary activity in recent studies.
Methods: 50 patients with migraine headache (13 patients in attack, 26 patients in post-attack and 11 patients in interval period) and 60 healthy volunteers were taken into the study. In all participants, the presence of anxiety was measured by using Hamilton Anxiety Rating scale. The visual analog scale scores for pain level estimation were obtained in the attack group.
Results: The salivary alpha amylase levels were significantly lower in attack period (p<0.01) and higher in post-attack period (p<0.01) when compared with the control group. There was not any significant difference in salivary alpha amylase levels between interval period and control group (p>0.05). There was a weak negative correlation between the salivary alpha amylase levels and the visual analog scale scores.
Conclusions: This is the first study showing the dynamic nature of sympathetic nervous system activity by evaluating the salivary alpha amylase levels-a noninvasive, reliable and an easy method-in different periods of migraine headache.
Similar articles
-
High salivary alpha-amylase levels in patients with schizophrenia: A pilot study.Prog Neuropsychopharmacol Biol Psychiatry. 2010 May 30;34(4):688-91. doi: 10.1016/j.pnpbp.2010.03.024. Epub 2010 Mar 27. Prog Neuropsychopharmacol Biol Psychiatry. 2010. PMID: 20347911
-
Salivary alpha-amylase activity: a possible indicator of pain-induced stress in orthodontic patients.Pain Med. 2011 Aug;12(8):1162-6. doi: 10.1111/j.1526-4637.2011.01185.x. Epub 2011 Jul 12. Pain Med. 2011. PMID: 21749637
-
Determinants of salivary alpha-amylase in humans and methodological considerations.Psychoneuroendocrinology. 2009 May;34(4):469-85. doi: 10.1016/j.psyneuen.2008.12.004. Epub 2009 Jan 19. Psychoneuroendocrinology. 2009. PMID: 19155141 Review.
-
Salivary alpha-amylase stability, diurnal profile and lack of response to the cold hand test in young women.Stress. 2009 Nov;12(6):549-54. doi: 10.3109/10253890902822664. Stress. 2009. PMID: 19658030
-
α-Amylase as a reliable and convenient measure of sympathetic activity: don't start salivating just yet!Psychoneuroendocrinology. 2011 May;36(4):449-53. doi: 10.1016/j.psyneuen.2010.12.019. Epub 2011 Feb 3. Psychoneuroendocrinology. 2011. PMID: 21295411 Review.
Cited by
-
Protein Signature in Saliva of Temporomandibular Disorders Myalgia.Int J Mol Sci. 2020 Apr 7;21(7):2569. doi: 10.3390/ijms21072569. Int J Mol Sci. 2020. PMID: 32272779 Free PMC article.
-
Influence of hydrotherapy on clinical and cardiac autonomic function in migraine patients.J Neurosci Rural Pract. 2016 Jan-Mar;7(1):109-13. doi: 10.4103/0976-3147.165389. J Neurosci Rural Pract. 2016. PMID: 26933356 Free PMC article.
-
Diagnosis of Pain Deception Using Minnesota Multiphasic Personality Inventory-2 Based on XGBoost Machine Learning Algorithm: A Single-Blinded Randomized Controlled Trial.Medicina (Kaunas). 2024 Dec 2;60(12):1989. doi: 10.3390/medicina60121989. Medicina (Kaunas). 2024. PMID: 39768870 Free PMC article. Clinical Trial.
-
Salivary Alpha-Amylase in Experimentally-Induced Muscle Pain.Diagnostics (Basel). 2020 Sep 20;10(9):722. doi: 10.3390/diagnostics10090722. Diagnostics (Basel). 2020. PMID: 32962201 Free PMC article.
-
Oral and Gut Dysbiosis in Migraine: Oral Microbial Signatures as Biomarkers of Migraine.Neurol Neuroimmunol Neuroinflamm. 2025 Sep;12(5):e200437. doi: 10.1212/NXI.0000000000200437. Epub 2025 Jun 30. Neurol Neuroimmunol Neuroinflamm. 2025. PMID: 40699951 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical